The Value of 18F-PSMA-1007 PET/CT in Predicting Pathological Upgrading and Downgrading of Newly Diagnosed Prostate Cancer

被引：0
|
作者：
Zheng, Anqi [1 ]
Wang, Zhuonan [2 ]
Luo, Liang [2 ]
Chang, Ruxi [1 ]
Gao, Jungang [1 ]
Wang, Bo [1 ]
Duan, Xiaoyi [2 ]
机构：
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Peoples R China
[2] Xi An Jiao Tong Univ, Affiliated Hosp 1, PET CT Ctr, Xian, Peoples R China
来源：
JOURNAL OF NUCLEAR MEDICINE | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P770
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Evaluation of 18F-PSMA-1007 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy
    Zhou, Xing
    Jiang, Xiao
    Liu, Luzhou
    Wang, Xiaoxiong
    Li, Chuan
    Yao, Yutang
    Kou, Ying
    Shen, Jiaqi
    Shen, Taipeng
    Li, Zeng
    Yang, Shengke
    Zhou, Shukui
    Liao, Hong
    Luo, Zhifu
    Wu, Xiaoai
    Chen, Shirong
    Cheng, Zhuzhong
    TRANSLATIONAL ONCOLOGY, 2022, 15 (01):
  • [42] Comparison of the 18F-PSMA-1007 and 18F-FAPI-42 PET/ CT in the evaluation of prostate cancer and correlation between PSMA and FAPI uptake
    Mu, X.
    Li, M.
    Fu, W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S536 - S536
  • [43] Diagnostic Efficacy of 18F-PSMA-1007 in Staging of Prostate Cancer
    Gourevich, K.
    Koskosi, A.
    Keidar, Z.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S598 - S598
  • [44] Detection of Local Relapse of Prostate Cancer With 18F-PSMA-1007
    Seifert, Robert
    Schafigh, Darius
    Boegemann, Martin
    Weckesser, Matthias
    Rahbar, Kambiz
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (06) : E394 - E395
  • [45] Diagnostic value of integrated 18F-PSMA-1007 PET/MRI compared with that of biparametric MRI for the detection of prostate cancer
    Zeng, Yuping
    Leng, Xiaoming
    Liao, Hengbin
    Jiang, Guihua
    Chen, Ping
    PROSTATE INTERNATIONAL, 2022, 10 (02) : 108 - 116
  • [46] 18F-PSMA-1007 and 18F-fluorocholine PET/CT in prostate cancer progression diagnostics. First comparative experience
    Meshcheriakova, N. A.
    Dolgushin, M. B.
    Pronin, A., I
    Matveev, V. B.
    Odzharova, A. A.
    Nevzorov, D., I
    ONKOUROLOGIYA, 2019, 15 (03): : 70 - 76
  • [47] Intra-Individual Comparison of 18F-PSMA-1007 and 18F-FDG PET/CT in the Evaluation of Patients With Prostate Cancer
    Zhou, Xing
    Li, YingChun
    Jiang, Xiao
    Wang, XiaoXiong
    Chen, ShiRong
    Shen, TaiPeng
    You, JinHui
    Lu, Hao
    Liao, Hong
    Li, Zeng
    Cheng, ZhuZhong
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [48] Anthracosis: a potential pitfall in 18F-FCH PET/CT and 18F-PSMA-1007 PET/CT interpretation
    Cimini, A.
    Ricci, M.
    Marzullo, A.
    Menichini, M.
    Di Stasio, F.
    Di Pietro, M.
    Arabi, H.
    Dadgar, H.
    Gravina, G. L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S250 - S250
  • [49] Atypical neoplastic solitary focal uptake of 18F-PSMA-1007 in PET/CT in patients with biochemically recurrent prostate cancer
    Antonevskaya, T. L.
    Khalimon, A. I.
    Khodzhibekova, M. M.
    Atakishieva, L. U.
    Khamadeeva, G. F.
    Khodakova, D. Yu.
    Lazutina, T. N.
    Pylova, I. V.
    Volchenko, N. N.
    Leontyev, A. V.
    ONKOUROLOGIYA, 2023, 19 (04): : 131 - 138
  • [50] Hemangioma of the Ilium Simulating Bone Metastasis on 18F-PSMA-1007 PET/CT
    Dong, Aisheng
    Nian, Shensheng
    Bai, Yushu
    Zuo, Changjing
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (06) : e304 - e306
12345